Type : |
Artikel |
Internetlink : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=284 |
|
Onderzoeksgroepen : |
Houston - M.D.Anderson Cancer Center |
Auteur : |
Zhang YP, Trissel LA, Fox JL. |
Titel : |
Naratriptan hydrochloride in extemporaneously compounded oral suspensions. |
Nummer : |
Int J Pharm Compound ; 4: 69-71. 2000 |
|
Niveau van bewijs : |
|
Fysische stabiliteit : |
|
Chemische stabiliteit : |
|
Andere methoden : |
|
Reacties : |
|
Stoffenlijst
Naratriptan Hydrochloride
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
23°C |
|
7 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|
|
15 mg Amerge® |
OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
4°C |
|
90 |
|
|
|
|
|